← Eichor
Condition: Intracardiac Thrombus Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Intracardiac Thrombus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus
Phase N/A · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06146751
Apixaban Versus Warfarin for Left Ventricular Thrombus
Phase 3 · 1 location(s) · University of Arizona · NCT07709780
Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population
Phase N/A · 1 location(s) · Azienda Ospedaliero, Universitaria Ospedali Riuniti · NCT06371170
Cerebral Microembolization Associated With PFO Closure
Phase N/A · 1 location(s) · China National Center for Cardiovascular Diseases · NCT06347276
Intracardiac Echocardiography Guided Watchman Device Implant
NA · 1 location(s) · The Cleveland Clinic · NCT06007872
[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
Phase 3 · 1 location(s) · Brigham and Women's Hospital · NCT07560306
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.